Methylenedioxyhydroxyamphetamine

Methylenedioxyhydroxyamphetamine
Systematic (IUPAC) name
(±)-1-(benzo[d][1,3]dioxol-5-yl)-N-hydroxylpropan-2-amine
Clinical data
Legal status
Identifiers
CAS Number 74698-47-8
ATC code None
PubChem CID 98528
ChemSpider 88979
Chemical data
Formula C10H13NO3
Molar mass 195.22 g/mol

3,4-Methylenedioxy-N-hydroxyamphetamine (MDOH, MDH) is an entactogen, psychedelic, and stimulant of the phenethylamine and amphetamine chemical classes. It is the N-hydroxy homologue of MDA, and the N-desmethyl homologue of MDHMA. MDOH was first synthesized and assayed by Alexander Shulgin.[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin listed the dosage range as 100–160 mg, and the duration as approximately 3–6 hours.[2] He describes MDOH as being very psychedelic and producing increased pleasure in beauty and nature.[3] He also mentioned several negative side effects also seen with MDMA ("Ecstasy") such as difficulty urinating and internal dryness.[4]

See also

References

External links


This article is issued from Wikipedia - version of the Monday, October 12, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.